Page 394 - SAHCS HIVMed Journal Vol 20 No 1 2019

Page 7 of 8 Original Research

number of women entering ANC on PCART will rise. Authors’ contributions
Our findings suggest that 80% of women on PCART accessing V.N. conceptualised and provided the initial design of the
antenatal care in a South African semirural setting are study, was responsible for all interviews and data collection,
virologically suppressed. Though below the aspirational undertook the initial analysis and interpretation of results
target of 90% suppression rate by 2020, it is encouraging, as and was the lead author in the writing of the manuscript.
16
is the zero MTCT rate we noted.
R.J.H. contributed to the design of the study, the analysis and
interpretation of results, and the writing of the manuscript.
There is a need for further study, including qualitative studies W.P.M. contributed to the design of the study and data
to delineate both the causal factors driving viraemia in collection.
pregnancy and its natural history, particularly in terms of the
development of maternal virological failure and the rate of References
vertical transmission. Viraemia rates are still too high, and
the factors responsible for this need to be identified and their 1. Joint United Nations Programme on HIV/AIDS. The gap report. Geneva,
prevention built into PMTCT programmes, including Switzerland: Joint United Nations Programme on HIV/AIDS; 2014.
attention to upstream factors such as education and the 2. Joint United Nations Programme on HIV/AIDS. UNAIDS data 2017. Geneva,
Switzerland: Joint United Nations Programme on HIV/AIDS; 2017.
prevention of unplanned pregnancies. 58 3. Joint United Nations Programme on HIV/AIDS. Global report: UNAIDS report on
the global AIDS epidemic 2010. Geneva, Switzerland: Joint United Nations
Programme on HIV/AIDS; 2010. Report No.: 9291738719.
We identified two areas of particular concern. Firstly, 72% of 4. South African National Department of Health. The 2012 national antenatal
pregnancies were unplanned in a population of patients on sentinel HIV & Herpes simplex type-2 prevalence survey in South Africa. Pretoria,
South Africa: South African National Department of Health; 2013.
ART, thus depriving them and their partners of the opportunity 5. Myer L, Phillips T, Manuelli V, et al. Evolution of antiretroviral therapy services for
for protective measures such as timed intercourse, planned HIV-infected pregnant women in Cape Town, South Africa. J Acquir Immune Defic
Syndr. 2015;69:e57–e65. https://doi.org/10.1097/QAI.0000000000000584
interruption of regular condom use and pre-exposure 6. Laut KG, Shepherd LC, Pedersen C, et al. Associations between HIV-RNA-based
prophylaxis for the non-infected partner. Even in the remaining indicators and virological and clinical outcomes. AIDS. 2016;30:1961–1972.
28%, we found no evidence of planning of conception in https://doi.org/10.1097/QAD.0000000000001144
collaboration with healthcare service providers. Secondly, we 7. Hermans LE, Moorhouse MA, Carmona S, et al., editors. Increased risk of cART
failure after low-level viremia under WHO guidelines. Conference on retroviruses
were unable to determine birth outcomes for 18% of our and opportunistic infections; 2017 Feb 13–16; Seattle, WA.
pregnancies despite our best efforts, which speaks to the 8. Nachega JB, Uthman OA, Anderson J, et al. Adherence to antiretroviral therapy
during and after pregnancy in low-income, middle-income, and high-income
fragmentation of our healthcare system even within the countries: A systematic review and meta-analysis. AIDS. 2012;26:2039–2052.
https://doi.org/10.1097/QAD.0b013e328359590f
PMTCT cascade, as well as serious deficits in communication 9. Jordan MR, Bennett DE, Bertagnolio S, Gilks CF, Sutherland D. World Health
and sharing of critical information between providers. Organization surveys to monitor HIV drug resistance prevention and associated
factors in sentinel antiretroviral treatment sites. Antivir Ther. 2008;13:15.
10. Gallant JE. Making sense of blips. J Infect Dis. 2007;196:1729–1731. https://doi.
Finally, we have shown that self-reported non-adherence org/10.1086/523705
using the VAS has value. The VAS is not commonly employed 11. Sorstedt E, Nilsson S, Blaxhult A, et al. Viral blips during suppressive antiretroviral
treatment are associated with high baseline HIV-1 RNA levels. BMC Infect Dis.
for the assessment of adherence in our environment. 2016;16:305. https://doi.org/10.1186/s12879-016-1628-6
However, it is a quick and simple method and should be 12. Tobin NH, Learn GH, Holte SE, et al. Evidence that low-level viremias during
developed further as part of routine patient assessment. effective highly active antiretroviral therapy result from two processes: Expression
of archival virus and replication of virus. J Virol. 2005;79:9625–9634. https://doi.
org/10.1128/JVI.79.15.9625-9634.2005
Conclusion 13. Gandhi RT, McMahon DK, Bosch RJ, et al. Levels of HIV-1 persistence on
antiretroviral therapy are not associated with markers of inflammation or
activation. PLoS Pathog. 2017;13:e1006285. https://doi.org/10.1371/journal.
One-fifth of HIV-positive pregnant women on PCART are ppat.1006285
viraemic at antenatal booking. ART programmes miss the 14. Elvstam O, Medstrand P, Yilmaz A, et al. Virological failure and all-cause mortality
in HIV-positive adults with low-level viremia during antiretroviral treatment. PLoS
opportunity to either optimise viral suppression in this group of One. 2017;12:e0180761. https://doi.org/10.1371/journal.pone.0180761
women before conception occurs or to offer contraception 15. Ryscavage P, Kelly S, Li JZ, Harrigan PR, Taiwo B. Significance and clinical
management of persistent low level viremia and very low level viremia in HIV-1
services. Non-adherence is a very important factor in viraemia, infected patients. Antimicrob Agents Chemother. 2014;58(7):3585–98. https://
doi.org/10.1128/AAC.00076-14
and a concerted effort by both healthcare workers and patients 16. Joint United Nations Programme on HIV/AIDS. 90-90-90: An ambitious treatment
is necessary to achieve optimum adherence to ART. The rate of target to help end the AIDS epidemic. Geneva, Switzerland: Joint United Nations
Programme on HIV/AIDS; 2014.
unplanned pregnancies is high; therefore, more action is required 17. Peters R, Kekana M, Cole-Hamilton S, Mongwe MW, Railton J. Towards the HIV
to meet the contraception needs of HIV-positive women as 90-90-90 target: A simple and low-cost intervention to improve viral load
pregnancy prevention is an effective means of PMTCT. More completion. HIV Nurs Matt. 2016;7:35–39.
effective integration of such services as family planning, ARV 18. Mzingwane ML, Tiemessen C, Richter KL, et al. Pre-treatment minority HIV-1 drug
resistance mutations and long term virological outcomes: Is prediction possible?
treatment, reproductive health, maternal and neonatal services, Virol J. 2016;13:170. https://doi.org/10.1186/s12985-016-0628-x
as recommended in national guidelines, is necessary. 59 19. Bull L, Khan AW, Barton S. Management of HIV infection in pregnancy. Obstet
Gynaecol Reprod Med. 2015;25:273–278. https://doi.org/10.1016/j.ogrm.
2015.07.004
Acknowledgements 20. Mandelbrot L, Tubiana R, Le Chenadec J, et al. No perinatal HIV-1 transmission
from women with effective antiretroviral therapy starting before conception. Clin
Infect Dis. 2015;61:1715–1725. https://doi.org/10.1093/cid/civ578
Competing interests 21. Reliquet V, Winer N, Chereau N, et al. The spectrum of HIV mother-to-child
transmission risk. J Int AIDS Soc. 2014;17:19703. https://doi.org/10.7448/IAS.
The authors declare that they have no financial or personal 17.4.19703
relationship(s) that may have inappropriately influenced 22. Kennedy CE, Yeh PT, Pandey S, Betran AP, Narasimhan M. Elective cesarean
section for women living with HIV: A systematic review of risks and benefits. AIDS.
them in writing this article. 2017;31:1579. https://doi.org/10.1097/QAD.0000000000001535

http://www.sajhivmed.org.za 387 Open Access